Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation

Cardiovascular Research

Volumn 34, Issue 2, 1997, Pages 411-417

  Tiefenbacher, Christiane P ^a   Chilian, William M ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Coronary vasculature; Endothelium; Fibroblast growth factor; Heparin; L NMMA; Nitric oxide; Pig, coronary artery; Potassium channel, ATP sensitive; Prostaglandins; Vasodilation

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GLIBENCLAMIDE; HEPARIN; INDOMETACIN; MONOCLONAL ANTIBODY; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL; PROSTAGLANDIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL TONE; CONTROLLED STUDY; CORONARY BLOOD VESSEL; EXTRACELLULAR MATRIX; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GLYBURIDE; HEPARIN; INDOMETHACIN; MICROSCOPY, VIDEO; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; POTASSIUM CHANNELS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SWINE; VASODILATION;

EID: 0030915241     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00029-1     Document Type: Article

References (36)

1. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM. Platelet derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res 1992;71:1088-1100.
2. Battler A, Scheinowitz M, Bor A, et al. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol 1993;22:2001-2006.
3. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science Wash DC 1992;257:1401-1403.
4. Banai S, Jaklitsch MT, Casscells W, et al. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ Res 1991;69:76-85.
5. Unger EF, Banai S, Shou M, Jaklitsch MT, Epstein SE. Intracoronary injection of basic fibroblast growth factor enhances collateral blood flow in the canine myocardium. Circulation 1991;84(Suppl I):II-96(Abstract).
6. Sellke FW, Wang SY, Friedmann M, et al. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am J Physiol 1994;267:H1303-H1311.
7. Rosenblatt S, Irikura K, Caday CG, Finklestein SP, Moskowitz MA. Basic fibroblast growth factor dilates pial arterioles. J Cereb Blood Flow 1994;14(1):70-74.
8. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G. Hypotensive activity of fibroblast growth factor. Science 1991;254:1208-1210.
9. Berk BC, Alexander RW, Brock TA, Gimbrone MA Jr, Webb RC. Vasoconstriction: A new biological activity of platelet-derived growth factor. Science 1986;232:87-90.
10. Vlodavsky I, Folkman J, Sullivan R, et al. Endothelial cell derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci 1987;84:2292-2296.
11. Reed JA, Albino AP, McNutt NS. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995;72(2):215-222.
12. Folkmann J, Klagsbrunn M, Sasse J, Wadzinski M, Ingber D, Vlodasky I. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol 1988;130(2)393-400.
13. Guyton J, Rosenberg R, Clowes A, Karnovsky MJ. Inhibition of rat arterial smooth muscle cell proliferation by heparin. I. In vivo studies with anticoagulant and non-anticoagulant heparin. II. In vitro studies. Circ Res 1980;47:578-584.
14. Mandal AK, Lyden TW, Saklayen MG. Heparin lowers blood pressure: Biological and clinical perspectives. Kidney Int 1995;47:1017-1022.
15. Gospodarowicz D, Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 1986;128:475-484.
16. DeBlois C, Cote MF, Doillon CJ. Heparin-fibroblast growth factor-fibrin complex: in vitro and in vivo application to collagen-based materials. Biomaterial 1994;15(9):665-672.
17. Kan, M, Wang F, Xu J, Crabb JW, Hou J, McKeehan WL. An essential heparin-binding domain in the fibroblast growth factor kinase. Science 1993;259:229-231.
18. Yayon A, Klagsbrunn M, Esko JD, Leder P, Ornitz DM. Cell surface heparin-like molecules are required for binding of FGF to its high affinity receptor. Cell 1991;94:841-848.
19. Rapraeger AC, Krufka A, Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991;252:1705-1708.
20. Presta M, Maier JAM, Rusnati M, Ragnotti G. Basic fibroblast growth factor: production, mitogenic response, and post-receptor signal transduction in cultured normal and transformed fetal bovine aortic endothelial cells. J Cell Physiol 1989;140:68-74.
21. Flaumenhaft R, Moscatelli D, Rifkin DB. Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J Cell Biol 1990;111:1651-1659.
22. Jaques LB. Heparin: An old drug with new paradigm. Science 1979;206:528-533.
23. Yokokawa K, Tahara H, Kohno M, Mandal AK, Yanagisawa M, Takeda T. Heparin regulates endothelin-production through endothelium-derived nitric oxide in human endothelial cells. J Clin Invest 1993;92:2080-2085.
24. Carroll SM, White FC, Roth DM, Bloor CM. Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion. Circulation 1993;88:198-207.
25. Susic D, Mandal AK, Kentera D. Heparin lowers the blood pressure in hypertensive rats. Hypertension 1982;4:681-685.
26. Kuo L, Davis MJ, Chilian WM. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol 1990;259:H1063-H1070.
27. Chilian WM, Eastham CL, Marcus ML. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol 1986;251:H779-H788.
28. Ishizaka H, Kuo L. Acidosis-induced coronary arteriolar dilation is mediated by ATP-sensitive potassium channels in vascular smooth muscle. Circ Res 1996;78:50-57.
29. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993;265:H586-H592.
30. Lefer AM, Tsao P, Aoki N, Palladino MA Jr. Mediation of cardioprotection by transforming growth factor-b. Science 1990;249:61-64.
31. Wilson SK, Solez K, Biotnott FK, Heptinstall RH. The effects of heparin treatment on hypertension and vascular lesions in stroke-prone spontaneously hypertensive rats. Am J Pathol 1981;102:62.
32. Abbott EC, Gornall AG, Sutherland DJ, Laidlaw JC, Stiefel M. The influence of a heparin-like compound on hypertension, electrolytes and aldosterone in man. Can Med Assoc J 1966:94:1155-1164.
33. Linstead VH, Schmidt H, Kaulhausen H, Breuer H. Wirkung von Heparin in vitro auf die Reninaktivität im Plasma. Klin Chem Klin Biochem 1972;10:512.
34. Ito H, Takikawa R, Iguchi M, Hamada E, Sugimoto T, Kurachi Y. Heparin uncouples the muscarinic receptor from Gk protein in the atrial cell membrane of the guinea-pig heart. Pflügers Arch 1990;417:126-128.
35. Spivak-Kroizman T, Lemmon MA, Dikic I, et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation and cell proliferation. Cell 1994;79:1015-1024.
36. Roghani M, Moscatelli D. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan-sulfate-mediated mechanisms. J Biol Chem 1992;267(31):22156-22162.